The effect of remdesivir and nirmatrelvir/ritonavir on mortality in patients hospitalized with COVID-19 during the Omicron era: an emulated target trial Article Swipe
Related Concepts
No concepts available.
John Karlsson Valik
,
Pontus Hedberg
,
Piotr Nowak
,
Ola Blennow
,
Robert Dyrdak
,
Jan Vesterbacka
,
Johan Zetterqvist
,
Pontus Nauclér
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.cmi.2025.09.012
· OA: W4414412285
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.cmi.2025.09.012
· OA: W4414412285
Treatment with remdesivir and/or nirmatrelvir/ritonavir was associated with reduced mortality in hospitalized SARS-CoV-2-infected patients during the Omicron era, primarily in unvaccinated individuals without previous infection. Our findings support prioritizing nonimmune individuals for antiviral treatment.
Related Topics
Finding more related topics…